High doses of some statins may provide cancer protection

05/16/2008 | Reuters

A new study found people who took high doses of statins that are lipophilic, or soluble in fats -- such as Lipitor, Zocor and Mevacor -- had a 25% lower risk of cancer than those who did not use the cholesterol-lowering medications. People taking a lower dose reduced their cancer risk by 11%.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN